Yasmin Abaza is an Oncology physician affiliated with Northwestern University. OpenAlex indexes 130 publications with 1,659 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
675 N Saint Clair St Ste 21-100
Chicago, IL 606115970
Telephone
312-695-0990Provider last certified this registry record 6 Oct 2020.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20254 payments$11,096openpaymentsdata.cms.gov ↗
- Geron CorporationProgram year202514 payments
- ABBVIE INC.Program year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
55.7%CD38-directed Cytolytic Antibody27.6%Daratumumab100%Part B, office-administered≥13 patientsPD-1 inhibitor27.4%Pembrolizumab100%Part B, office-administered≥11 patients+ 3 more classes in this area
Dermatology
22.7%Corticosteroid22.5%Methylprednisolone sodium succinate100%Part B, office-administered≥14 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.2%Acyclovir100%Part D<11 patientsAnti-infectives
15%Human Immunoglobulin G14.6%Immune globulin100%Part B, office-administered≥19 patientsAzole Antifungal0.2%Posaconazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025
Journal of the National Comprehensive Cancer Network
2025 - Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Blood Cancer Journal
2025 - Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment
Journal of Clinical Investigation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University
Philip Greenland, MD
Northwestern University
Peter Kahrilas, MD
Northwestern University
Philip Gorelick, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”